Serum Pro-coagulation Tube

01

Product Description

Its core technology lies in uniformly spraying coagulant at the interior wall. In traditional blood collection tubes, complete coagulation takes 30-60 minutes; The pro-coagulation tube activates fibrinogen in the blood, converting soluble fibrin into insoluble fibrin polymers, enabling rapid blood coagulation within 10 minutes. The serum samples obtained after centrifugation are clear, free of fibrin filament precipitation, and can be tested directly on the machine, greatly shortening sample pre-processing time. 

Due to its rapid serum separation capabilities, the  pro-coagulation tube is mainly used in emergency and intensive care settings , routine biochemical and immunological testing, and blood bank and matching experiments.

02

Core Advantages

1. Ultimate time efficiency: The red-capped pro-coagulation tube actively activates  coagulation cascade through exogenous coagulant agents, reducing coagulation time to within 10 minutes. This allows laboratories to complete centrifugation and computer-based testing within 15-20 minutes after blood collection, directly transforming into a diagnostic decision window. 

2. Improved sample purity: High-quality coagulant can form dense blood clots with sufficient contraction. After centrifugation, the serum interface is clear with no fibrin residue, allowing samples to be directly loaded into the machine without secondary processing.

03

Economic Benefits

Uniqueness:Significant reduction in hidden costs. Although the procurement cost of a single red-cap pro-coagulant tube may be slightly higher than that of a no additive tube, from an overall operational perspective:
Saves equipment loss: Reduces needing to replace or stop the machine for maintenance due to fibrin blockage
Improved Personnel Efficiency: No need for manual monitoring of coagulation status, reducing workstation dwell time for sample preprocessing
Avoiding redraw costs: The "sample disqualification-notification of redraw" process caused by poor coagulation or insufficient serum release is costly for both hospitals and patients (patient suffering, nurses performing secondary operations, laboratory returns, and delayed reporting).